PK/PD & Disease Models

Pharmacokinetic (PK), pharmacodynamic (PD) and disease models help synthesize and focus our quantitative understanding of the disease and clinical pharmacology of the drug with respect to the endpoint(s) targeted. These models are useful for interpolation, and when mechanistic, can be useful for extrapolation to experimental conditions not yet evaluated.